Quick Answer
STAAR SURGICAL CO reported R&D Expense of $40.05 million for fiscal year 2025.
STAAR SURGICAL CO R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $40.05M | -11.6% |
| 2024 | $45.32M | +12.0% |
| 2023 | $40.48M | +12.5% |
| 2022 | $35.98M | +6.3% |
| 2021 | $33.86M | +6.1% |
| 2020 | $31.92M | +26.2% |
| 2019 | $25.30M | +14.8% |
| 2018 | $22.03M | +9.9% |
| 2017 | $20.04M | -3.0% |
| 2016 | $20.67M | +40.0% |
| 2015 | $14.76M | +19.4% |
| 2014 | $12.36M | +84.3% |
| 2013 | $6.71M | +4.1% |
| 2012 | $6.44M | +9.8% |
| 2011 | $5.87M | +2.5% |
| 2010 | $5.72M | -2.9% |
| 2009 | $5.89M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.21M | -24.8% | -10.3% |
| June 30, 2025 | $10.26M | -13.5% | -24.9% |
| March 31, 2025 | $13.66M | +2.1% | +11.6% |
| September 30, 2024 | $12.25M | +6.8% | +3.2% |
| June 30, 2024 | $11.87M | +1.0% | -11.3% |
| March 31, 2024 | $13.38M | +29.8% | +16.7% |
| September 30, 2023 | $11.47M | +19.3% | -2.4% |
| June 30, 2023 | $11.76M | +36.1% | +14.0% |
- STAAR SURGICAL CO showed a decrease of -11.6% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, STAAR SURGICAL CO’s r&d expense has grown by 579.7% (from $5.89 million to $40.05 million).
- The most recent figure is from STAAR SURGICAL CO’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: